Monday, November 30, 2015
Monday, November 23, 2015
Friday, November 20, 2015
Tuesday, November 17, 2015
Monday, November 16, 2015
Thursday, November 12, 2015
Friday, November 6, 2015
THE CHANGING LANDSCAPE OF BOTULINUM TOXIN DELIVERY
Revance's RT002 beats BOTOX in mid-stage study; shares up 58% premarket--
Oct 29 2015, 08:44 ET | About: Revance Therapeutics, ... (RVNC) | By: Douglas W. House, SA News Editor 
Thursday, November 5, 2015
Subscribe to:
Posts (Atom)